Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0002318
UniProt IDP31321
Primary gene name(s)PRKAR1B
Synonym gene name(s)unknown
Protein namecAMP-dependent protein kinase type I-beta regulatory subunit
Protein functionRegulatory subunit of the cAMP-dependent protein kinases involved in cAMP signaling in cells. {ECO:0000269|PubMed:20819953}.
Subcellular locationCell membrane {ECO:0000269|PubMed:23115245}.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: P31321
Gene Ontology
(Biological Process)
Complete annatation
activation of protein kinase A activity [GO:0034199];
blood coagulation [GO:0007596];
cellular response to glucagon stimulus [GO:0071377];
learning or memory [GO:0007611];
negative regulation of cAMP-dependent protein kinase activity [GO:2000480];
protein phosphorylation [GO:0006468];
renal water homeostasis [GO:0003091]
Gene Ontology
(Molecular Function)
Complete annatation
cAMP binding [GO:0030552];
cAMP-dependent protein kinase inhibitor activity [GO:0004862];
cAMP-dependent protein kinase regulator activity [GO:0008603];
protein kinase A catalytic subunit binding [GO:0034236]
Gene Ontology
(Cellular Component)
Complete annatation
cAMP-dependent protein kinase complex [GO:0005952];
ciliary base [GO:0097546];
cytosol [GO:0005829];
plasma membrane [GO:0005886]
Protein-protein interaction111561
Phylogenetic treeP31321
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD30.9751562598262360.03067381632890120.0662533332916593
AZA vs. DISU-0.5210787270644260.04575872401601330.485039366672959
AZA vs. IL70.3764594436278680.05985834748836790.703798825350824
AZA vs. SAHA-0.9346584298938430.0002927233527796340.00870317913175581
DISU vs. CD3-1.50831047785380.001200759564120690.00485001330909842
DISU vs. IL70.8884801028058310.0006208092035451250.0195788676641062
DISU vs. SAHA-0.4128178987410690.1732105500320890.536716541988804
DMSO vs. AZA0.003570096776128240.9841434968189661
DMSO vs. CD3-0.9857749691508550.02534395766938610.0545516105571227
DMSO vs. DISU0.5219768037352060.0379603748744930.393170343201793
DMSO vs. IL70.3808766915232810.04197111754896720.413484360909863
DMSO vs. SAHA-0.9434983168057360.000146094885091430.00462562187649778
HIV vs. Mock in Activation0.1513916826084420.8721752976351520.999983755607037
HIV vs. Mock in Latency-0.1579509823578970.3703016712136810.999834320637052
IL7 vs. CD3-0.591976983367720.1780311037310840.295437941928728
SAHA vs. CD3-1.934396616681345.76432303501795e-050.000294237202672495
SAHA vs. IL7-1.314349518359923.06428633134459e-071.65196665321887e-05
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
-0.3975 0.03267

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) FALSE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK -0.999153 0.000305467
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
0.774 0.817 0.63 0.645 0.69
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

PDB Accession Method Resolution Chain Structure Preview
4DIN X-ray 3.7Å B=1-381.
4F9K X-ray 2.8Å A/B/C/D=11-73.

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

HIV Partner Interaction Type PubMed
matrix phosphorylated by 9151826
Tat activates 9278385
Nef phosphorylated by 15629779
Vif inhibited by 18836454
Vpr phosphorylated by 20392842
matrix activates 1978848

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa04910 Insulin signaling pathway - Homo sapiens (human)